The board of biotechnology group Sirtex Medical has agreed to a $1.6 billion takeover offer from United States giant Varian Medical Systems, after revealing it received a number of takeover offers in late 2017.
The all-cash offer is priced at $28 a share, a 49 per cent premium to the $18.83 price that Sirtex shares last traded at before they were suspended on Tuesday morning.
Loading...
James Thomson is senior Chanticleer columnist based in Melbourne. He was the Companies editor and editor of BRW Magazine. Connect with James on Twitter. Email James at j.thomson@afr.com
